Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Certain pre-existing health conditions may mean these medications aren't suitable for you
If you exercise regularly but have plateaued in your fat loss or body composition goals, the issue may not be your training plan or your nutrition
A Phase 2 RCT published in NEJM 2023 reported a mean body weight reduction of approximately 24% at 48 weeks with the 12 mg weekly dose in adults with obesity
No information on this page is intended as a personal dosing recommendation
Post-injection care: Do not rub the injection site, as this may affect medication absorption
Increased Thyroid Cancer Risk Not Observed After Use of GLP1 Receptor Agonist Ariana Pelosci Patients who are predisposed to medullary thyroid cancer should be advised against the use of GLP1 agents
US$ 28.25
US$ 23.00
US$ 24.03
